Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Janus Kinase Inhibitors [MoA]: Side Effects & Safety Data for 6 Drugs

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Janus Kinase Inhibitors [MoA] includes 6 drugs with a combined 303,277 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.

6
Drugs in Class
303,277
Combined Reports

All Janus Kinase Inhibitors [MoA] Drugs Ranked by Reports

Drug Brand Name Reports Deaths Hosp. Death Rate
TOFACITINIB XELJANZ XR 155,647 7,847 21,976 5.0%
RUXOLITINIB OPZELURA 68,133 10,908 14,461 16.0%
UPADACITINIB Rinvoq 65,656 2,406 15,931 3.7%
BARICITINIB Olumiant 8,108 717 2,498 8.8%
ABROCITINIB CIBINQO 3,170 57 329 1.8%
PACRITINIB Vonjo 2,563 292 455 11.4%

Common Side Effects in Janus Kinase Inhibitors [MoA] Drugs

Side EffectReportsDeaths
Drug ineffective 36,584 1,699
Pain 28,165 1,902
Off label use 26,599 3,418
Fatigue 21,905 2,034
Arthralgia 20,893 1,624
Condition aggravated 18,930 1,661
Rheumatoid arthritis 15,330 1,775
Headache 15,269 1,497
Diarrhoea 12,502 1,618
Pain in extremity 12,371 1,100
View detailed side effects for this class → Compare drugs in this class →